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Abstract: The microenvironment of mesenchymal stem cells (MSCs) is responsible for the modulation
in MSC commitment. Nanocomposites with an inorganic and an organic component have been
investigated, and osteogenesis of MSCs has been attributed to inorganic phases such as calcium
phosphate under several conditions. Here, electrospun meshes and two-dimensional films of
poly(lactic-co-glycolic acid) (PLGA) or nanocomposites of PLGA and amorphous calcium phosphate
nanoparticles (PLGA/aCaP) seeded with human adipose-derived stem cells (ASCs) were analyzed for
the expression of selected marker genes. In a two-week in vitro experiment, osteogenic commitment
was not found to be favored on PLGA/aCaP compared to pure PLGA. Analysis of the medium
revealed a significant reduction of the Ca2+ concentration when incubated with PLGA/aCaP, caused
by chemical precipitation of hydroxyapatite (HAp) on aCaP seeds of PLGA/aCaP. Upon offering a
constant Ca2+ concentration, however, the previously observed anti-osteogenic effect was reversed:
alkaline phosphatase, an early osteogenic marker gene, was upregulated on PLGA/aCaP compared to
pristine PLGA. Hence, in addition to the cell–material interaction, the material–medium interaction
was also important for the stem cell commitment here, affecting the cell–medium interaction. Complex
in vitro models should therefore consider all factors, as coupled impacts might emerge.
Keywords: adipose-derived stem cells; PLGA; amorphous calcium phosphate nanoparticles; calcium
ions; gene expression
1. Introduction
Discovering microenvironments that direct the osteogenic commitment of stem cells is currently
one of the central topics in the field of bone repair and regeneration. Supplements, such as calcium
ions [1], bone morphogenetic proteins (BMPs) [2], dexamethasone [3] and bioactive peptides [4,5] in the
culture media of stem cells trigger the intended differentiation towards the osteoblast phenotype [6].
Apart from adding supplements, co-cultures [7], microtissues [8] or mechanical stimulation [9–11] are
Int. J. Mol. Sci. 2020, 21, 2627; doi:10.3390/ijms21072627 www.mdpi.com/journal/ijms
Int. J. Mol. Sci. 2020, 21, 2627 2 of 16
promising approaches in this regard. Moreover, the composition of a material acting as a scaffold [12],
its surface properties [13], pore size and pore connectivity [14] are essential for the specific commitment
of stem cells.
With the aim of mimicking natural bone, its composition and structure has been profoundly
analyzed [15,16]. From the knowledge obtained, fabrication of biomaterials resembling bone structure
could be further developed, not only for tissue engineering but also for coating of inert implant
materials [17]. A mineralized collagen fibril forms the main building block of bone tissue, with the
most abundant mineral phase consisting of hydroxyapatite (HAp) [18]. On the other hand, the organic
phase is primarily composed of collagen I, which constitutes approximately 20 wt% of the bone
substance [19]. Hence, implant materials intended for bone regeneration often include a mineral and an
organic component, among others [20]. The use of calcium phosphate compounds as inherent entities
in bone void fillers or scaffold materials aimed at tissue engineering has recently gained considerable
interest. Several reports on novel materials containing calcium phosphate nanoparticles elucidate their
potential [21–27]. The inorganic phase incorporated within an organic carrier may act beneficially in
terms of osteogenic commitment; for example, fibroblast-derived extracellular matrix (ECM) sheets
for the replacement of the periosteum promoted osteogenic differentiation of human mesenchymal
stem cells (MSCs) [28] when covered with calcium phosphate particles. Another study reports the
effect of biphasic calcium phosphate (BCP) nanoparticles embedded in polyvinyl alcohol/gelatin [29].
The presence of those nanoparticles affected the protein expression of MG-63 cells by upregulation of
collagen I and osteopontin as early as 3 and 7 days in vitro. Moreover, in vivo application revealed the
beneficial effect of these inorganic nanoparticles: in a rat model, 50 wt% of BCP resulted in increased
bone formation 2 and 4 weeks post-implantation [29]. Nevertheless, the impact on the commitment of
MSCs may vary depending on the exact chemical composition, crystallinity, solubility and size of the
calcium phosphate particles included in the organic phase.
In our previous work, we focused on a nanocomposite based on poly(lactic-co-glycolic acid)
(PLGA) and amorphous calcium phosphate nanoparticles (PLGA/aCaP, weight ratio 60:40) seeded
with human adipose-derived stem cells (ASCs) [11,30–32]. Moreover, the gene expression of primary
human ASCs seeded on a thin casted film made of either PLGA or PLGA/aCaP or on electrospun
random fiber meshes (PLGA or PLGA/aCaP) was assessed to investigate the effects of the structure
and material composition [33].
The goal of the current study was to evaluate the impact of aCaP nanoparticles in PLGA
composites on the gene expression of ASCs when seeded on the materials in vitro. The exposition
of calcium phosphate nanoparticles to ASCs, either in a 2D or in a 3D microenvironment, may affect
their commitment.
The hypotheses were that
(i) aCaP nanoparticles in PLGA evoke the osteogenic commitment of ASCs in basal medium;
(ii) osteogenic commitment—as evoked by aCaP nanoparticles—is enhanced in osteogenic
induction medium;
(iii) 3D fiber meshes of PLGA/aCaP evoke osteogenic commitment even to a greater extent than do
corresponding 2D flat films of PLGA/aCaP.
2. Results
2.1. Material Characterization
First, the materials without cells were characterized by means of SEM and X-ray diffraction
(XRD) (Figure 1 and supporting information Figure S1). The aCaP nanoparticles are visible before
incubation on PLGA/aCaP scaffolds using SEM (Figure 1A) and its amorphous phase is confirmed
by XRD (Figure 1C). Upon incubation in culture medium without cells, crystalline hydroxyapatite
(Figure 1B,D) was formed only on composites containing aCaP nanoparticles. X-ray measurements
Int. J. Mol. Sci. 2020, 21, 2627 3 of 16
show the shift from a wide peak assigned to amorphous aCaP (Figure 1C) [34] to the sharp crystalline
peaks of HAp (Figure 1D) [35].
 
γ
Figure 1. SEM images of the surface of poly(lactic-co-glycolic acid) (PLGA) and amorphous calcium
phosphate nanoparticles (PLGA/aCaP) fabricated as films or electrospun meshes (A). On the surface,
the films made of PLGA are flat, in contrast to the PLGA/aCaP films, where the nanoparticles can
be seen quite well (increased magnification in Figure S1). The surface of the scaffolds was analyzed
by means of SEM after (B) incubation for 2 weeks in DMEM at 37 ◦C (B). Hydroxyapatite crystals
can be observed on 2D and 3D PLGA/aCaP scaffolds. The formation of hydroxyapatite on material
with incorporated aCaP nanoparticles was confirmed by X-ray diffraction (XRD) pattern ((C): before
incubation; (D): after incubation) [35]. The black dot denotes the aCaP phase.
2.2. Seeding Adipose-Derived Stem Cells and Gene Expression Analysis
Then, the scaffolds were seeded with human adipose-derived stem cells (Figure 2). After two
weeks, osteogenic marker genes ALP, Runx2, collagen I and osteocalcin were analyzed. Moreover, in
addition to minimal stem cell markers CD73, CD90 and CD105, some other genes were selected, such
as CD31 and CD34 (endothelial), PPAR-γ-2 (adipogenic) and Sox9 (chondrogenic). The presence of the
aCaP nanoparticles in PLGA led to a significant downregulation of osteogenic markers genes (Figure 3
and supporting information Figure S2). In addition to ALP, Runx2 and collagen I expression (3D, DMEM
and 3D, OS), osteocalcin (3D, DMEM) was also reduced. There was no significant upregulation of
osteogenic marker genes—neither for the two architectures (2D and 3D) nor for the two culture media
(DMEM and OS).
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Figure 2. The 2D and 3D scaffolds of PLGA and PLGA/aCaP, shown without cells in (A), were
seeded with adipose-derived stem cells for 14 days, shown in (B). The interaction between cells and
material seems to be enhanced on scaffolds containing calcium phosphate compounds because of aCaP
nanoparticles and newly formed hydroxyapatite (Hap), while biofilm formation is observed on pristine
PLGA rather than adhesion of the cells as found for PLGA/aCaP.
 
Figure 3. Manifold gene expression of human adipose-derived stem cells (ASCs) seeded on PLGA or
on PLGA/aCaP realized as casted films or as electrospun random fiber meshes. The fold change of
aCaP-seeded PLGA compared to pure PLGA is shown in (A) ALP, Runx2 and collagen I, (B) osteocalcin,
(C) CD31, CD34, PPAR-γ-2 and Sox9, (D) CD 73, CD105 and CD 90. Values at 1.0 (dashed line) indicate no
change in gene expression, whereas higher values indicate enhanced gene expression if aCaP nanoparticles
are present. Key: OS = osteogenic medium. The p-values of pairwise comparison of one-way ANOVA
statistics were considered significant if p < 0.05, denoted by *. **, p < 0.01; ***, p < 0.001. For significant
differences between PLGA/aCaP and PLGA, we refer to SI Figures S1 and S2.
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The analysis of the changes in gene expression for other markers revealed a significant upregulation
for CD31 expression in 3D, DMEM as well as for CD34 expression in 2D, DMEM, but also a significant
downregulation for CD31 in 2D, DMEM and for CD34 in 3D, DMEM. In osteogenic medium, CD31
and CD34 genes were unaffected. There was also no change in the gene expression of PPAR-γ-2 and
Sox9, neither for 2D and 3D nor for the two culture media.
Stem cell markers CD73 and CD90 were significantly affected when seeded on the nanocomposite
compared to pure PLGA. While CD73 experienced an upregulation in 3D, DMEM and 3D, OS, CD90
was downregulated in DMEM (both 2D and 3D) and in 3D, OS.
2.3. Free Calcium Ion Concentration
As a further step, cell-free 2D films and 3D electrospun meshes of PLGA ± aCaP nanoparticles
were incubated in DMEM to gain further insights into the interaction between the medium and material
itself (no cells present). The concentration of free calcium ions in the supernatant was measured before
and after every medium change (Figure 4). The Ca2+ concentration in the supernatant of calcium
phosphate-containing composites was reduced significantly after incubation at 37 ◦C for up to 14
days (medium change time interval: 3 or 4 days), while pristine PLGA did not indicate any change
compared to the basal concentration in the medium.
γ
Figure 4. Ca2+ ion concentration of DMEM medium exposed to either PLGA or PLGA/aCaP random
fiber meshes and films. On PLGA/aCaP materials, calcium ions are reduced in 2D film to 0.5 mM and in
3D electrospun meshes to 1.3 mM. The p-values of pairwise comparison of one-way ANOVA statistics
were considered significant if p < 0.05, denoted by *. **, p < 0.01; ***, p < 0.001.
In vivo, calcium ions are continuously delivered by diffusion and a constant level remains over
time (Figure 5). In our specific system, however, the formation of HAp and other calcium phosphate
phases led to a decrease in free calcium ion concentration (Figures 4 and 5).
Calcium ion levels in the medium in contact with only PLGA was measured to be approximately
2.0 mM, which is the usual Ca2+ concentration in DMEM with 10% fetal bovine serum (FBS) (basal
medium) after 3 days of incubation time (Figure 4). ACaP nanoparticles can act as initial nuclei for
crystallization and precipitation of inorganic phases composed of calcium and phosphate (Figure 6).
Consequently, the Ca2+ in the supernatant of the calcium phosphate-containing material was reduced to
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0.52 ± 0.08 mM (2D) resp. 1.33 ± 0.17 mM (3D), a 3.8-fold (2D) and 1.5-fold (3D) reduction, respectively.
Normalized to the weight of the discs, the decrease is 0.08 mM (2D) and 0.24 mM (3D) per µg of
incubated material. Hence, the 3D electrospun meshes depleted their supernatant medium 3-fold more
efficiently than the 2D films.
 
Figure 5. Studying potential bone grafts is often performed under in vitro conditions. Highly
osteoconductive materials lead to the rapid formation of calcium phosphate crystal hydroxyapatite
(HAp). In consequence, the free calcium ion in the medium depletes. In such cases, in vitro studies are
not able to mimic in vivo conditions anymore, since continuous supply of minerals, such as Ca2+, is
given by diffusion under in vivo conditions.
Figure 6. The interaction of material and medium is illustrated and influences several cellular pathways
leading to distinct cell differentiation. Bone scaffolds with incorporated calcium phosphate nanoparticles
induce the formation of hydroxyapatite, and thus the deposition of calcium ions decreases free calcium
in the medium, which reduces osteoinduction significantly. On pure PLGA, no interaction of material
and medium, such as mineral precipitation, is observed and therefore leads to usual calcium ion
concentrations and normal osteoinduction.
2.4. Providing Excess Culture Medium
In light of these findings, further experiments with 3D electrospun meshes in excess medium
were conducted, i.e., 10-fold more medium, warranting a constant free calcium ion concentration
(supporting information Figure S3). Under these excess medium conditions, gene expression revealed
that ALP was significantly upregulated in PLGA/aCaP compared to PLGA (Figure 3). This can be
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confirmed by the significant lower ∆CT of the PLGA/aCaP 3D, excess DMEM compared to PLGA 3D,
DMEM (supporting information Figure S4).
While CD31 expression was significantly downregulated on films in DMEM and upregulated in
3D meshes in DMEM (non-excess), it was not affected in the excess system. CD34 expression, however,
was significantly upregulated by a factor of 10 in the presence of aCaP when the cell-seeded meshes
were cultivated in excess DMEM (Figure 3). The analysis of PPAR-γ-2 and Sox9 as representative genes
for adipogenic and chondrogenic commitment, respectively, revealed a significant downregulation
when seeded on PLGA/aCaP compared to PLGA (Figure 3). Finally, under excess medium conditions
and with regard to stem cell markers, only CD73 and CD90 were significantly upregulated; CD105 was
not affected (Figure 3).
2.5. Mineralization
Micro-CT analysis of 3D random fiber meshes revealed that the bone volume (BV) fraction
increased in OS compared to DMEM when PLGA was the material of choice; however, there was no
increase in the BV fraction between OS and DMEM when PLGA/aCaP was used (Figure 7).
Figure 7. The bone volume (BV)/total volume (TV) (= bone volume fraction) is given for the two
different materials (PLGA and PLGA/aCaP) in the two different culture media (DMEM and osteogenic
medium = OS). The bone volume fraction (BV/TV) was assessed for the ASC-seeded three-dimensional
random fiber meshes after 14 days cultured in vitro (see Materials and Methods). Below, there are
typical micro-CT images of a PLGA scaffold: surface (left) and cross-section (right), scale bars = 1 mm.
The p-values of pairwise comparison of one-way ANOVA statistics were considered significant if
p < 0.05, denoted by *. **, p < 0.01; ***, p < 0.001.
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3. Discussion
The microenvironment of stem cells directs their fate with regard to differentiation [36]. In order
to elucidate the effect of aCaP nanoparticles incorporated in PLGA on the gene expression of human
stem cells, 3D electrospun meshes and 2D films made of PLGA and PLGA/aCaP, respectively, were
used and cultivated either in basal or in osteogenic culture medium. After two weeks, a time point
when the changes in commitment were hypothesized to become evident, osteogenic marker genes ALP,
Runx2, collagen I and osteocalcin were analyzed. During the time course of osteogenic differentiation,
early upregulated genes include ALP [37], Runx2, followed by collagen I and later osteocalcin expression.
In contrast to our expectations, the presence of the aCaP nanoparticles in PLGA led to a significant
downregulation of these osteogenic markers.
Although previous in vivo studies in rabbits [38] and sheep [39] clearly demonstrated that the
PLGA/aCaP nanocomposite acted as osteoconductive materials and supported bone regeneration
as a bone void filler, the exposure of human ASCs seeded on PLGA/aCaP in vitro showed the
opposite—based on gene expression results, there was an anti-osteogenic commitment.
As calcium plays a pivotal role in several signaling pathways [40,41], changing free calcium ion
levels may lead to other results that do not represent in vivo conditions. Enhanced Ca2+ deposition,
which is the case for highly osteoconductive materials [42], may lead to Ca2+ depletion in vitro if there
is not sufficient Ca2+ available to replenish the deficit; however, in vivo, the calcium concentration is
generally maintained at constant as Ca2+ is continuously delivered to sites with transiently lowered
concentrations [43].
Therefore, cell-free 2D films and 3D electrospun meshes of PLGA ± aCaP nanoparticles were
incubated in DMEM and analysis of the supernatant revealed a significant depletion of the free Ca ion
concentration in case of the nanocomposite PLGA/aCaP; however, this was not the case for pure PLGA,
where no changes in free Ca ion concentration were found. Obviously, the in vitro conditions used
in this study differed from typical in vivo conditions with respect to free calcium ion levels; in vivo,
calcium ions are continuously delivered by diffusion, leading to a constant level over time. In our
specific system, however, the formation of HAp and other calcium phosphate phases led to a decrease
in free calcium ion concentration, which affected the commitment of the ASCs.
In light of these findings, further experiments with 3D electrospun meshes in excess medium were
conducted, i.e., 10-fold more medium, warranting a constant free calcium ion concentration. As culture
medium, DMEM was chosen because it was hypothesized that it was more difficult to reverse the
observed anti-osteogenic effect by providing a constant Ca2+ concentration in basal medium DMEM
than in osteogenic induction medium. The 3D meshes were used as they had been shown to induce a
3-fold higher free calcium depletion per mass of scaffold compared to the 2D films.
As originally expected, gene expression revealed that ALP was significantly upregulated in
PLGA/aCaP compared to PLGA after two weeks. ALP is an early osteogenic marker, usually
upregulated within the first week after incubation with OS. However, as we used basal medium
without further supplementation, it seemed reasonable that it was upregulated after 2 weeks. Thus, an
early osteogenic commitment was confirmed—evoked by the presence of aCaP nanoparticles in PLGA.
The other osteogenic markers analyzed here, Runx2 and collagen I, still experienced a downregulation,
as was the case under non-excess conditions, while osteocalcin was not affected. While upregulation of
Runx2 had been expected because it is known to be responsible for (i) the pre-osteoblastic commitment
of stem cells [44] and (ii) the activation of ALP during pre-osteoblastic differentiation [45], the osteogenic
commitment of collagen I and osteocalcin usually appears later during the osteogenic differentiation
process, explaining these findings. For ALP, however, the expected upregulation in the presence of
aCaP nanoparticles incorporated in PLGA was confirmed.
In addition, one remarkable change in gene expression under excess medium conditions was the
10-fold upregulation of CD34. This significant CD34 upregulation on meshes in excess DMEM in the
presence of aCaP nanoparticles may have induced other functional cues in addition to the commitment
towards an endothelial cell type; induction of CD34 gene expression in ASCs might also be attributed
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to replicative capacity and stemness in addition to endothelial cell-related pathways [46]. In addition,
although most of the ASC subpopulations are CD34-, it has been reported that approximately 8% of
the cells may be CD34+. As shown for another source of mesenchymal stem cells from peripheral
blood, CD34+ stem cells are easily differentiated towards the osteoblastic phenotype. It is noteworthy
to mention that in excess DMEM, CD31 did not experience an upregulation, while there was this high
impact on CD34. Aguirre et al. have shown that CD34+ progenitor cells from bone marrow had a weak
CD31 expression, but nevertheless could differentiate into mature endothelial cells [47].
The analysis of PPAR-γ-2 and Sox9 as representative genes for adipogenic and chondrogenic
commitment, respectively, revealed a significant downregulation when seeded on PLGA/aCaP
compared to PLGA under excess medium conditions. These findings are coherent with the initial
commitment of the ASCs found for the osteogenic phenotype; while ALP was significantly upregulated,
adipogenic and chondrogenic commitment were suppressed.
As for the impact of aCaP nanoparticles in PLGA meshes and in the presence of a constant calcium
ion concentration, only CD73 and CD90 were significantly upregulated; CD105 was not affected.
Although CD90 was downregulated in the systems investigated under calcium depletion, it was
upregulated in excess DMEM. During differentiation, typical stem cell markers should theoretically
be downregulated, as the gene expression changes and stemness is lost upon lineage commitment.
Interestingly, we found an upregulation here, which might show that these stem cell marker genes are
sensitive towards calcium in a different way.
Finally, the micro-CT analysis revealed that the BV fraction increased in OS compared to DMEM
when PLGA was used, but not between DMEM and OS for PLGA/aCaP. Hence, the difference in BV/TV
between PLGA/aCaP and PLGA was larger in DMEM than in OS. Combining results from cellular
and non-cellular incubation leads to the conclusion that calcium phosphate phases produced by cells
are only reflected in BV fractions on PLGA (where BV/total volume (TV) OS > DMEM). In contrast,
on PLGA/aCaP, the contribution of cells to BV/TV is superimposed by (i) aCaP nanoparticles already
incorporated and (ii) chemical HAp precipitation of calcium ions from the medium induced by the
nanoparticles, levelling off BV/TV to approximately 0.35. Moreover, dissolution of calcium phosphate
phases should not be neglected and may add to these findings of similar BV/TV for PLGA/aCaP in
both culture media.
Many studies hypothesized that the presence of 40 wt% aCaP nanoparticles incorporated in PLGA
either realized as casted films (2D) or as electrospun random fiber meshes (3D) would promote the
osteogenic commitment of ASCs, as observed in previous preclinical studies in vivo. In contrast, when
using a classical in vitro setup with limited fluidic exchange, we found an overall downregulation of
early osteogenic markers, with some exceptions—and these exceptions were always found for the 2D
system realized by casted films. We analyzed the supernatant medium for calcium levels as the direct
local interaction of cells with the substrate is not the only important factor for stem cell fate. It was
found that the presence of aCaP nanoparticles significantly decreased the free calcium ion concentration.
Hence, extracellular calcium levels and, consequently, intracellular calcium levels might have a more
important impact on the modulation of stem cell fate as compared to direct interactions with inorganic
nanoparticles incorporated in PLGA (solid phase). Medium composition and substrate composition are
coupled variables because they influence each other and, together, they affect the gene expression of the
cells in contact with both the substrate and the medium, respectively. We were able to compensate and
attenuate the decrease in free calcium ion concentration by a 10-fold increase in the medium volume.
Under this high ratio of culture medium-to-scaffold volume, we found the typical increase in ALP gene
expression in the presence of aCaP nanoparticles. Together, starting osteogenesis and the commitment
of a subpopulation towards the endothelial cell type—which had been shown for the chosen cell line
before [31]—established PLGA/aCaP as a good bone biomimetic scaffold under in vitro conditions
without further medium supplementation, providing constant extracellular calcium concentrations.
A limitation of this study is the finding that although a constant free calcium ion concentration was
provided to cells seeded on PLGA/aCaP in excess DMEM and although the expected ALP upregulation
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was confirmed, the typical osteogenic marker gene Runx2 was downregulated. We currently do not
know exactly why this was the case. We can only speculate that Runx2 upregulation after a two-week
incubation might have taken place but was already over or that the experimental system (excess
DMEM) evoked other not anticipated effects, such as a faster downregulation after having triggered
upregulation first. In other words, the downregulation of Runx2 after a first quick upregulation might
have been accelerated by the special culture conditions used here.
Nevertheless, when we look back at our initial hypotheses of the study, the outcome shows that
indeed aCaP nanoparticles incorporated in PLGA evoke an osteogenic commitment in ASCs cultivated
in basal medium but only if a constant free calcium ion concentration is provided. We conclude that
all possible reactions, including the interaction/equilibrium of the material with the medium, should
be considered when in vitro experiments are performed. Above all, when seeding stem cells on an
osteoconductive composite material for bone tissue engineering, the free calcium ion concentration in
equilibrium with the solid phase has a non-negligible impact on the fate of commitment, in addition to
the direct local interaction of the cells with the solid phase, including impacts of surface topography
and substrate stiffness. In addition to the significant increase in ALP gene expression, the provision of
a constant calcium ion concentration also enhanced CD34 expression significantly. Although CD34
does not belong to the set of typical osteogenic marker genes, it is notable that a constant calcium
ion concentration also affects other commitments in addition to osteogenic commitment, particularly
if stem cells are used that exhibit a donor-specific heterogeneity. Thus, in addition to cell–material
interactions, it is important to also investigate the impact of the free calcium ion concentration on the
cells seeded on a material. The actual calcium ion concentration might be influenced by the solid
substrate, particularly if calcium phosphate phases are incorporated. This aspect has to be taken into
consideration when osteoinduction of bone-mimicking scaffold materials are discussed.
4. Materials and Methods
4.1. Scaffolds
Clinically approved PLGA (85:15) was obtained from Boehringer Ingelheim. Flame spray
pyrolysis was used to prepare the aCaP nanoparticles (Ca/P = 1.5), as described earlier [48], using
calcium-2-ethylhexanoic salt (synthesized with calcium hydroxide from Riedel de Haen, Ph. Eur. and
ethylhexanoic acid from Sigma-Aldrich, Zurich, Switzerland) and tributyl phosphate (Sigma-Aldrich,
98%, Zurich, Switzerland). The preparation of PLGA/aCaP nanocomposites was based on previous
protocols [49]. The aCaP nanoparticles were dispersed in chloroform (Riedel de Haen, Ph. Eur.) with 5
wt% Tween20 (polysorbate20, Fluka, Ph. Eur.) using an ultrasonic probe (Ultrasonic Homogenizer
FS-450N, Sonorex, Bandelin, Switzerland). The dispersion (PLGA/aCaP= 60/40 wt%) was supplemented
with 8 wt% PLGA in chloroform, and the mixture was stirred overnight at room temperature.
The PLGA/aCaP dispersions and the pure PLGA solutions were electrospun (IME EC-CLI, feeding
rate: 3 mL/h; relative humidity: 50%, distance tip-collector: 15 cm; voltage applied: 20 kV; tip kept
in a chloroform airstream) [49]. The surface of the scaffolds was imaged using scanning electron
microscopy (SEM, FEI, Nova NanoSEM 450, Baltec, Balzers, Lichtenstein). Scaffolds seeded with cells
were fixed with 2.5% glutaraldeyde (Axonlab, Baden, Switzerland) and osmium tetroxide (Sigma
Aldrich, Zurich, Switzerland) and dried using critical point drying (Tousimis, Rockville, Maryland)
prior to SEM analysis. In order to assess the primary diameter of the nanoparticles (~ 22 nm), we used
transmission electron microscopy (TEM, FEI, Philips CM 12, TSS microscopy, New York, NY, USA).
Disks with a diameter of 1 cm and a thickness of 500–600 µm were prepared with electrospun PLGA
and PLGA/aCaP [32]. Moreover, films were prepared from solvent-casted films for 2D cell culture
studies. The films had a diameter of 3 cm. The crystalline phases of hydroxyapatite formation and aCaP
were investigated by means of SEM and X-ray diffraction (XRD). XRD patterns were collected on an
X’Pert PRO-MPD and analyzed with X’Pert Highscore Plus software. After incubation in DMEM, the
XRD samples were washed with deionized water and dried at room temperature prior to measurement.
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4.2. Non-Cellular Scaffold Incubation
To determine non-cellular hydroxyapatite deposition leading to changes in calcium concentration
in the medium, PLGA ± aCaP discs (3D meshes and 2D films, respectively) were incubated in 2 mL
DMEM with 10% of FBS and Antibiotic-Antimycotic 1X (Thermo Fisher Scientific, Basel, Switzerland)
for two weeks at 37 ◦C and 5% CO2, changing the medium every 3 or 4 days. A control was included
using the medium without discs. Sample size was n = 3. The calcium concentration remaining in the
solution of the samples was measured by a colorimetric assay kit (Sigma-Aldrich, Zurich, Switzerland)
using a microplate reader (Tecan, Spark, Männedorf, Switzerland).
4.3. Cell Isolation
Human ASCs were isolated from fat tissue with the informed consent of the patient according to
Swiss (Züricher Kantonale Ethik-Kommission KEK-ZH: StV 7-2009) and international ethical guidelines
(ClinicalTrials.gov Identifier: NCT01218945), as reported by Buschmann et al. [50]. The extraction
procedure was performed following Zuk et al. [6] and approved by the Swiss ethical guidelines
(KEK-ZH: StV 7-2009). ASCs were characterized according to established procedures [32,51]. Of
the 30 isolated primary ASC lines [50], we selected one. This selection was based on previous
findings regarding its differentiation capacity—it differentiated easily towards the endothelial cell
(EC) phenotype, towards adipocytes and chondrocytes and moderately to well towards osteoblasts
(OBs) [31]. The fat for these primary cells had been received from a 29-year-old woman by abdominal
liposuction. This donor was chosen because it seemed to be a bigger challenge to evoke an osteogenic
commitment in ASCs, induced by the nanocomposite, than in ASCs that had previously shown
an easy osteogenic differentiation in the osteogenic culture medium, as tested during multilineage
differentiation [33].
4.4. Multilineage Cell Differentiation
Lineage-specific differentiation of ASCs towards the osteoblast, the endothelial, the adipogenic
and the chondrogenic cell lineage had been achieved previously [33] using cell culture media
supplementation according to Zuk et al. [6]. We used Von Kossa and Alizarin red staining in
order to semi-quantitatively assess the osteogenic differentiation extent; CD31 immunohistochemical
staining to evaluate the endothelial cell differentiation; Alcian Blue staining to determine the ability of
the ASCs to differentiate towards chondrocytes; Oil Red O staining to obtain information about the
adipogenic differentiation. These four differentiations had been carried out before for the primary cells
under view, using induction media, and results were presented earlier [33].
4.5. Tissue Engineered Constructs
Before seeding the cells, the PLGA and PLGA/aCaP discs, respectively, were immersed in 5 mL
DMEM medium (PAN Biotech, Aidenbach, Germany) containing 10% FBS and 50µg mL−1 gentamycine
for 15 min. Then, they were dried in the laminar flow bench. The 1.0 x 106 ASCs were seeded on both
sides of the disk. During seeding, the cells were distributed homogenously over the disk surfaces
(macroscopic evaluation). All seeded scaffolds were cultivated in 6-well plates using 2 mL DMEM
medium with 10% FBS and 50 µg mL−1 gentamycine or osteogenic medium (DMEM with 10% FBS,
50 µg ml−1 gentamycine, 10 mM beta-glycerophosphate, 50 µM ascorbic-2-phosphate and 100 nM
dexamethasone) for 2 weeks in a humidified atmosphere of 95% air and 5% CO2 at 37
◦C. In addition,
3D PLGA/aCaP meshes were incubated in excess DMEM (20 mL) in a Petri dish with a diameter of
10 cm. The medium was changed every 3 or 4 days. At the end of the experiment (2 weeks), the
samples were carefully collected and 14 was fixed overnight by 4% formalin in phosphate-buffered
saline (Kantonsapotheke Zurich), followed by histology. Another 14 was used for micro-CT analysis
and the rest for real-time polymerase chain reaction (PCR). For the film experiments, films were seeded
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with 1.0 × 106 ASCs and placed on the bottom of a 6-well plate either with osteogenic supplements (OS)
or without (DMEM). After 2 weeks of cultivation, cells were collected for PCR. Sample size was n = 3.
4.6. Gene Expression
Total RNA was extracted from the electrospun meshes or from the films with a RNeasy Mini
Kit (Qiagen). The kit was used according to the manufacturer’s instruction. A Nanodrop ND-1000
Spectrophotometer (Witec, Sursee, Switzerland) was used to quantify the RNA. A total of 500 ng
RNA was reversed transcribed into cDNA with oligo-dT primers (Invitrogen, Carlsbad, CA, USA),
DTT (Invitrogen), dNTP mix (Invitrogen), 5x FSB (Invitrogen), SuperscriptIII (Invitrogen) and RNA
inhibitor (Applied Biosystem, Buchs, Switzerland). SYBR® Green (Qiagen, Hilden, Germany) and
primers synthesized by Microsynth (Balgach, Switzerland) were used for quantitative PCR. For primer
sequences, see SI Table S1. Primers for CD73, CD90 and CD105 (minimal criteria [52]), for CD31
and CD34 (markers of endothelial cells), for ALP and RUNX2 (early osteogenesis), for collagen I
(medium osteogenesis) and osteocalcin (late osteogenesis), for PPAR-γ-2 (adipogenesis) and Sox9
(chondrogenesis) [53] were used.
4.7. Micro-CT
After fixation in 40% ethanol, the wet 3D electrospun scaffolds were scanned in a micro-CT 40
(Scanco Medical, Cressier, Switzerland) operated at 45 kV and 114 µA. Scans were executed using
a high-resolution mode, resulting in a voxel size of 8 µm. In reconstructed images, bone tissue was
segmented from background using a global threshold of 12% of maximum gray value. The following
parameters were determined: the total volume (TV), the bone volume (BV) and the bone volume
fraction (BV/TV).
4.8. Statistics
The data were analyzed with StatView 5.0.1 software. One-way statistical analysis of variance
(ANOVA) was conducted to test the significance of differences between different materials, different
culture media and between 2D films and 3D electrospun meshes. Unpaired t-tests were performed to
compare ∆Ct values of PLGA and PLGA/aCaP systems, respectively. Pairwise comparison probabilities
(p) were calculated using Fisher’s PLSD post-hoc test to evaluate differences between the groups.
p values < 0.05 were considered significant (denoted by *); **, p < 0.01; ***, p < 0.001. Values were
expressed as means ± standard deviations.
Supplementary Materials: Supplementary materials can be found at http://www.mdpi.com/1422-0067/21/7/2627/
s1.
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